Clinical Trials Logo

Clinical Trial Summary

Preconceptional use of low molecular weight heparin (enoxaparin) and aspirin in patient with recurrent miscarriages with positive anti phospholipid antibodies increase the implantation rate and the duration of pregnancy with low complications to the mother and the baby.


Clinical Trial Description

Preconceptional heparin during follicular or luteal phase,improves the implantation rate by increasing the blood flow and increasing the implantation factors,also decreasing the pregnancy complication resulting from Antiphospholipid Syndrome (APS). ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01661439
Study type Observational
Source Woman's Health University Hospital, Egypt
Contact Alaa Mahmoud Ismail, M.D
Phone +201000459514
Email dr.alaa_ismail@yahoo.com
Status Recruiting
Phase N/A
Start date March 2012
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT00456118 - Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
Terminated NCT01688284 - The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage N/A